Go, no-go decision making for phase 3 clinical trials: ACT IV revisited – Authors' reply

Michael Weller, Nicholas Butowski, David D. Tran, Lawrence D. Recht, Michael Lim, Hal Hirte, Lynn Ashby, Laszlo Mechtler, Samuel A. Goldlust, Fabio Iwamoto, Jan Drappatz, Donald M. O'Rourke, Mark Wong, Mark G. Hamilton, Gaetano Finocchiaro, James Perry, Wolfgang Wick, Jennifer Green, Yi He, Christopher D. TurnerMichael J. Yellin, Tibor Keler, Thomas A. Davis, Roger Stupp, John H. Sampson

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e709-e710
JournalThe Lancet Oncology
Volume18
Issue number12
DOIs
Publication statusPublished - Dec 1 2017

ASJC Scopus subject areas

  • Oncology

Cite this